Expanding histopathology tools for drug discovery 

Advanced histotechnology techniques enable accurate assessment of treatment outcomes, fueling pharmaceutical development. 

Histopathology is the gold standard for evaluating the efficacy and safety of new pharmaceuticals. Emerging molecular and digital pathology techniques have enhanced histopathology precision and image analysis, providing quantitative data to facilitate drug screening and guide clinical trial design. In this webinar brought to you by Inotiv, Douglas Peters and Laura Hoon-Hanks will discuss a range of cutting-edge histopathology tools that ensure high-quality results for various stages of the pharmaceutical development pipeline.

Topics to be covered

  • Molecular pathology techniques for protein and mRNA detection in tissue sections
  • Whole slide brightfield and fluorescence scanning for cell and spatial analysis
  • Anatomic pathology models for investigating drug efficacy and safety

Tuesday, October 24th, 2023 | 2:30 PM - 4:00 PM Eastern Time
This webinar will be available to view live and on demand.


Douglas Peters, PhD

Douglas Peters, PhD

Senior Manager, Digital Pathology

Laura Hoon-Hanks, DVM, PhD

Laura Hoon-Hanks, DVM, PhD

Associate Director, Investigative and Discovery Pathology 

Sponsored by